What we use gadolinium for

Where does it go, and why this element?

In 2008, 69% of all gadolinium went into magnets and 21% into phosphors. Gadolinium compounds also make MRI scans clearer. Doctors gave more than 460 million doses from 1988 to 2018. Gadolinium absorbs neutrons very well, so it is used in nuclear fuel and reactor shields.

Last updated 13 October 2026.

Where it goes

Where it goes (World)
Permanent magnets 69%
Phosphors 21%
Other 9.8%
2008. World use of gadolinium oxide in 2008, 762 t in all, from a USGS report based on data from Bade (2010). The report has no category for MRI contrast agents or nuclear uses. We found no newer world split for gadolinium alone1

The newest world split that we found is for 2008. In that year, the world used 762 tonnes of gadolinium oxide1:

  • Permanent magnets, 69%1.
  • Phosphors, 21%1.
  • Other uses, 10%1.

The USGS split has no category for MRI contrast agents or for nuclear uses. By mass, MRI is a small use. Brünjes and Hofmann estimate the gadolinium from MRI scans at 19 tonnes a year for the EU and 21 tonnes for the US2. That is about 40 tonnes, next to 762 tonnes of oxide for all uses in 2008. This is our rough comparison, for different years.

From 2016 to 2018, the EU used gadolinium for magnets, lighting, metals and MRI3. In 2025, magnets were the leading world use of all rare earths, by USGS estimate4.

Why this element

  • Magnets. Neodymium-iron-boron magnets hold small amounts of gadolinium5. The EU says that it is also used in samarium-cobalt magnets, for temperature compensation and resistance to corrosion3. The IEA says that it can replace dysprosium in magnets6.
  • MRI scans. Hospitals inject gadolinium compounds to make MRI images clearer7. The free gadolinium ion has a size close to that of the calcium ion. The RSC says that it could interfere with calcium in the body, so it cannot be used alone8. The agents hold the metal in a chelate, a molecule that binds it. Doctors gave more than 460 million doses from 1988 to 20182. In 2016, the EU and the US together did almost 200,000 of these scans a day2.
  • Neutron absorption. Natural gadolinium absorbs neutrons very strongly. Gadolinium-157 has a cross section of 259,000 barns7. So it is used in shields and control rods of nuclear reactors7. The IEA says that it is a burnable poison in nuclear fuel6.
  • Phosphors. Gadolinium compounds hold the phosphors in fluorescent lamps and X-ray screens. They are also used in scintillators for X-ray tomography7. In old television tubes, gadolinium oxide gave the green color3.
  • Alloys. As little as 1% gadolinium makes iron and chromium alloys easier to work. It also makes them resist high temperatures and oxidation8.
  • Magnetic cooling. Gadolinium is the only lanthanide that is ferromagnetic near room temperature. It loses this magnetism above 20 °C7. This makes it a common material for laboratory magnetic refrigerators7. The RSC says that magnetic fridges for general use may lie in the future8.

What could replace it

USGS says that substitutes exist for many uses of rare earths, but that they generally work less well4.

For MRI, Brünjes and Hofmann say that there is no practical alternative to gadolinium agents2. In lamps, LEDs need about 1,000 times less phosphor than fluorescent lamps, by the EU study3. In magnets, the EU table lists dysprosium and terbium as substitutes for gadolinium. It also lists gadolinium as a substitute for dysprosium3.

Where demand is going

The IEA expects demand for gadolinium to grow by about 4% a year to 2030. It names medical devices, nuclear control rods and its use instead of dysprosium in magnets6. An EU report of 2014 expected about 9% a year until 2020. The EU study of 2020 repeats this forecast, for magnets, magnetic cooling and medical imaging3. These are forecasts.

The EU says that LEDs now compete with fluorescent lamps, because their cost has fallen3. In its 2023 assessment, the EU found that lighting uses of gadolinium had fallen9.

MRI agents and the environment

Gadolinium agents from MRI scans pass through conventional sewage plants into rivers2. Scientists first reported unusually high gadolinium in rivers in 19962. In Germany, MRI scans put about 4 tonnes of gadolinium a year into waste water, by an estimate for 20162. The estimate assumes that half of all scans use an agent, with 1.1 g of gadolinium each2. For the EU and the US, see “Where it goes” above. Brünjes and Hofmann say that the levels in water are at least ten times below the toxic level of free gadolinium for people2.

In 2017, the European Medicines Agency found that gadolinium stays in brain tissue after the use of these agents. It found no evidence that this had harmed patients10. As a precaution, it recommended that the EU suspend three linear agents for injection into a vein10. Macrocyclic agents stay in use, because they release less gadolinium10.

In 2006, doctors first linked the agents to nephrogenic systemic fibrosis, a rare disease of the skin and organs2. Brünjes and Hofmann write that the agents are not recommended for patients with kidney failure2. In December 2017, the US FDA required a new class warning and a medication guide for these agents11. Brünjes and Hofmann write that the warning is especially for patients with kidney problems2. This text is not medical advice.

Sources

  1. 1

    U.S. Geological Survey (Thomas G. Goonan), 2011. Rare Earth Elements—End Use and Recyclability (Scientific Investigations Report 2011–5094) , Table 1 (gadolinium oxide row); sections on phosphors, permanent magnets and other uses.

    World use of gadolinium oxide by end use in 2008. Based on data from Bade (2010).

    • Gadolinium oxide ... 525 ... 162 75 762
    • Gadolinium oxide … 525 … 162 75 762
    • 69 percent of the consumption of gadolinium oxide (525 t)
    • of gadolinium oxide (162 t)
    • 9.8 percent
    • of the consumption of gadolinium oxide (75 t)
  2. 2

    Robert Brünjes and Thilo Hofmann, Water Research 182: 115966, 2020. Anthropogenic gadolinium in freshwater and drinking water systems , Sections 1 (introduction), 2 (sources and emissions), 5 (human health) and 7 (outlook).

    A review of gadolinium from MRI contrast agents in rivers and drinking water, with doses, emissions and health findings. Read with Firecrawl.

    • the corresponding figure for the whole of the EU is 19 tons, 21 tons for the US
    • Since GBCA’s use was first approved in 1988, more than 460 million doses have been administered worldwide up to 2018
    • In 2016, almost 200,000 MRI scans using GBCAs were conducted per day within the EU and the US combined
    • there is currently no viable alternative to GBCAs for medical use
    • they are not removed by conventional sewage treatment plants
    • Anomalous occurrences of Gd in rivers were first reported in 1996
    • an estimated annual emission of 4 tons of gadolinium
    • assuming 50% of all MRIs use GBCAs with 1.1 g Gd per MRI scan
    • at least an order of magnitude below the free Gd toxicity level for humans
    • in 2006 first links were established between nephrogenic systemic fibrosis (NSF) and GBCAs
    • The use of GBCAs is not recommended for patients with renal failure
    • requiring a new class warning especially for patients with kidney dysfunction
  3. 3

    European Commission (G.A. Blengini and others), 2020. Study on the EU's list of Critical Raw Materials (2020): Factsheets on Critical Raw Materials , Chapter 21, rare earth elements: sections 21.1.1.5, 21.2.2.5, 21.3.3.5, 21.4.2.5; Table 176 (global production of REO by element).

    Crust abundance, uses, demand forecast, EU use and trade, and estimates of world output of gadolinium oxide.

    • for magnets, lighting, metals and magnetic resonance imaging applications
    • Gd is primarly used in NdFeB alloys (Kiggins, 2015) but also in SmCo alloys
    • for temperature compensation and resistance to corrosion
    • Gadolinium oxide is used as a luminophore and gives the green color in television
    • 1000 times less
    • Dy Tb, Gd Gd Nd Dy, Tb
    • The overall demand for gadolinium is expected to increase by around 9% per year until
    • relating to uses in magnets (linked to a possible growth in magnetic refrigeration)
    • and in medical imagery (EC, 2014)
    • The falling cost of LEDs means that there is now a viable
  4. 4

    U.S. Geological Survey (Shelby N. Johnston), 2026. Rare Earths, in Mineral Commodity Summaries 2026 , Pp. 152-153: salient statistics (prices), recycling, events, world mine production and reserves, substitutes.

    Prices of gadolinium oxide from 2021 to 2025, China's export controls of 2025, world rare earth output and reserves.

    • the estimated leading global use was magnets
    • Substitutes are available for many applications but generally are less effective
  5. 5

    U.S. Geological Survey (Bradley S. Van Gosen, Philip L. Verplanck, Robert R. Seal II, Keith R. Long and Joseph Gambogi), 2017. Rare-earth elements, chapter O of Critical mineral resources of the United States (Professional Paper 1802-O) , Table O1 (crustal abundance); Uses and applications; Sources and production (China).

    Crustal abundance of gadolinium after Lide (2004), its uses in magnets, phosphors, MRI and control rods, and the ion-adsorption clays of southern China.

    • Lesser amounts of dysprosium
    • gadolinium, and praseodymium are also used in these
  6. 6

    International Energy Agency, 2026. Global Critical Minerals Outlook 2026 , Rare earth elements section: demand for non-magnet rare earths; nuclear section: control rods and burnable poisons.

    Forecast growth of gadolinium demand to 2030 and its use as a burnable poison in nuclear fuel.

    • a substitute for dysprosium in magnets
    • gadolinium is used as a burnable
    • gadolinium (used in medical devices and nuclear control rods and as
    • 4% per year
  7. 7

    Britannica Editors, Encyclopaedia Britannica, 2026. gadolinium .

    Properties, discovery, isotopes and neutron absorption, separation and metal production, uses, and the history of magnetic cooling. Read with Firecrawl; the site refused a script. Only the article text is used, not the machine-written answers above it.

    • MRI) contrast agent (in the form of water-soluble chelates)
    • with that of gadolinium-157 reaching 259,000
    • Other uses are in shields and control rods of
    • intensifying screens, and scintillators for X-ray tomography
    • Gadolinium is the only lanthanide that is
    • (ferromagnetic ordering) is 293
    • the metal became the magnetic refrigerant material of choice for numerous continuously operating laboratory magnetic refrigeration devices
  8. 8

    Royal Society of Chemistry, 2026. Gadolinium - Element information, properties and uses , Sections Uses and properties, Biological role, Natural abundance, History; podcast transcript.

    Discovery, name, first metal, uses, biological role, minerals, metal production and magnetic refrigeration.

    • The free Gd3+ ion has a similar ionic radius to Ca2+ but a greater charge, so gadolinium itself can not be used as it might interfere with various calcium roles
    • As little as 1% gadolinium can improve the workability of iron and chromium alloys, and their resistance to high temperatures and oxidation
    • Gadolinium may prove useful the fridges of the future
    • That use may lie in the future
  9. 9

    European Commission (M. Grohol and C. Veeh), 2023. Study on the Critical Raw Materials for the EU 2023: Final Report , Table A, major global supplier countries (row 17, gadolinium); results for gadolinium compared with 2020.

    China's share of world gadolinium supply at the processing stage, 2016-2020, and the change in its criticality scores.

    • towards increased magnets uses, and decreased lighting
  10. 10

    European Medicines Agency, 2017. EMA's final opinion confirms restrictions on use of linear gadolinium agents in body scans .

    News release of 21 July 2017 on the review of gadolinium in brain tissue and the restrictions on linear contrast agents.

    • gadolinium deposition occurs in brain tissues following use of gadolinium contrast agents
    • There is currently no evidence that gadolinium deposition in the brain has caused any harm to patients
    • All other intravenous linear products (gadodiamide, gadopentetic acid and gadoversetamide) should be suspended in the EU
    • are more stable and have a lower propensity to release gadolinium than linear agents
  11. 11

    Anthony Fotenos, US Food and Drug Administration, 2018. Update on FDA approach to safety issue of gadolinium retention after administration of gadolinium-based contrast agents , Slide 8.

    Slides for the FDA Pediatric Advisory Committee, 20 September 2018. They list the FDA steps on gadolinium retention, with the Drug Safety Communication of 19 December 2017 and its new class warning and medication guide. Read in a browser; the FDA page of December 2017 returns 404.

    • 12/19/2017: Drug Safety Communication
    • FDA requiring new class warning/medication guide